The constitutively active, GTP-bound variant of RAC1, RAC1b, is preferentially expressed in both colon and breast cancers, enhancing the downstream activation of NF-κB and the induction of cyclin D1 expression in a variety of solid tumors [24]. Here, CCND1 is linked to breast carcinoma.